title: Ipilimumab-induced hepatitis C viral suppression.
authors.affiliation: Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Steven
authors.initials: S
authors.lastname: Minter
authors.forename: Ira
authors.initials: I
authors.lastname: Willner
authors.forename: Keisuke
authors.initials: K
authors.lastname: Shirai
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D012878:Skin Neoplasms / Q000150:complications / Q000473:pathology*; D016896:Treatment Outcome; D019562:Viral Load / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D000074324:Ipilimumab